3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Head and Neck Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Meningeal Neoplasms
1
Meningeal Carcinomatosis
1
Melanoma
1
Lip Neoplasms
1
Kidney Neoplasms
1
Esthesioneuroblastoma, Olfactory
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Interventions
pembrolizumab
15
Nivolumab
9
atezolizumab
5
Ipilimumab
4
Drug Therapy
4
Docetaxel
4
Radiotherapy
3
Radiosurgery
3
Paclitaxel
3
Gemcitabine
3
Cetuximab
3
Carboplatin
3
Blood Specimen Collection
3
temsirolimus
2
spartalizumab
2
sargramostim
2
motexafin gadolinium
2
liposomal doxorubicin
2
entinostat
2
durvalumab
2
belinostat
2
Sirolimus
2
Psychiatric Rehabilitation
2
Peripheral Blood Stem Cell Transplantation
2
Metformin
2
Irinotecan
2
Fluorouracil
2
Etoposide
2
Dexamethasone
2
Cyclophosphamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Phlebotomy
×
Thoracic
×
Clear all
NCT04154163
2022-02-28
ADOPT
University of Dundee
Completed
18 enrolled